Exosome-mediated miR-222 transferring: An insight into NF-κB-mediated breast cancer metastasis
- PMID: 29778754
- DOI: 10.1016/j.yexcr.2018.05.014
Exosome-mediated miR-222 transferring: An insight into NF-κB-mediated breast cancer metastasis
Abstract
The subtypes of distant-organ metastasis led to treatment failure and poor prognosis are major obstacles in the management of patients with advanced breast cancer (BCa). Emerging evidences demonstrated that exosomes act as mediators for intercellular communication between various types of cells in the local tumor microenvironment. The present study aims to investigate whether BCa-derived exosomes are capable of cell-cell transferring miR-222 for BCa metastatic progression. Results showed that exosomal miR-222 is highly expressed in BCa patients with lymphatic metastasis. Consistently, the elevated levels of exosomal miR-222 are closely correlated with the high aggressivity of BCa cell lines. miR-222 promoting the aggressivity of BCa cells was confirmed in vitro and in vivo. Mechanistically, miR-222 directly targets PDLIM2, a tumor suppressor gene, leading to activation of NF-κB signal pathway. In conclusion, the levels of exosomal miR-222 are correlated with BCa metastatic progression. Exosome-transferred miR-222 promotes migration and invasion of BCa cells. miR-222 contributes to tumorigenicity of BCa cells through down-regulation of PDLIM2 and consequently activating NF-κB.
Keywords: Exosome; NF-κB and breast cancer; PDLIM2; miR-222.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer.J Cell Physiol. 2020 Jul;235(7-8):5722-5735. doi: 10.1002/jcp.29507. Epub 2020 Jan 22. J Cell Physiol. 2020. PMID: 31970775
-
Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.Theranostics. 2021 Feb 6;11(8):3932-3947. doi: 10.7150/thno.53412. eCollection 2021. Theranostics. 2021. PMID: 33664871 Free PMC article.
-
Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.Cancer Lett. 2020 Oct 1;489:87-99. doi: 10.1016/j.canlet.2020.05.038. Epub 2020 Jun 9. Cancer Lett. 2020. PMID: 32531321
-
Cytokine-mediated therapeutic resistance in breast cancer.Cytokine. 2018 Aug;108:151-159. doi: 10.1016/j.cyto.2018.03.020. Epub 2018 Mar 30. Cytokine. 2018. PMID: 29609137 Review.
-
Intercellular communication by exosome-derived microRNAs in cancer.Int J Mol Sci. 2013 Jul 9;14(7):14240-69. doi: 10.3390/ijms140714240. Int J Mol Sci. 2013. PMID: 23839094 Free PMC article. Review.
Cited by
-
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?Int J Oncol. 2020 Jan;56(1):47-68. doi: 10.3892/ijo.2019.4920. Epub 2019 Nov 25. Int J Oncol. 2020. PMID: 31789396 Free PMC article.
-
The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications.Oncogene. 2023 Oct;42(41):3017-3034. doi: 10.1038/s41388-023-02827-y. Epub 2023 Sep 5. Oncogene. 2023. PMID: 37670020 Free PMC article. Review.
-
Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.Mol Diagn Ther. 2020 Apr;24(2):215-232. doi: 10.1007/s40291-020-00453-y. Mol Diagn Ther. 2020. PMID: 32112368
-
Ginsenosides from Panax ginseng as Key Modulators of NF-κB Signaling Are Powerful Anti-Inflammatory and Anticancer Agents.Int J Mol Sci. 2023 Mar 24;24(7):6119. doi: 10.3390/ijms24076119. Int J Mol Sci. 2023. PMID: 37047092 Free PMC article. Review.
-
Exosome-Based Delivery of Natural Products in Cancer Therapy.Front Cell Dev Biol. 2021 Mar 2;9:650426. doi: 10.3389/fcell.2021.650426. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33738290 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical